EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 33 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,667 | +266.7% | 14,666 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 14,666 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 14,666 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -97.9% | 14,666 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $142,000 | +1477.8% | 14,666 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -35.7% | 14,666 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | – | 14,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |